- Home
- JBIO vs PMM Comparison
JBIO vs PMM Comparison
Compare JBIO & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBIO
- PMM
- Stock Information
- Founded
- JBIO 2024
- PMM 1989
- Country
- JBIO United States
- PMM United States
- Employees
- JBIO N/A
- PMM N/A
- Industry
- JBIO
- PMM Investment Managers
- Sector
- JBIO
- PMM Finance
- Exchange
- JBIO NYSE
- PMM Nasdaq
- Market Cap
- JBIO 290.1M
- PMM 265.3M
- IPO Year
- JBIO N/A
- PMM N/A
- Fundamental
- Price
- JBIO $8.28
- PMM $5.83
- Analyst Decision
- JBIO Strong Buy
- PMM
- Analyst Count
- JBIO 2
- PMM 0
- Target Price
- JBIO $15.50
- PMM N/A
- AVG Volume (30 Days)
- JBIO 397.1K
- PMM 118.3K
- Earning Date
- JBIO 08-05-2025
- PMM 01-01-0001
- Dividend Yield
- JBIO N/A
- PMM 4.68%
- EPS Growth
- JBIO N/A
- PMM N/A
- EPS
- JBIO N/A
- PMM 0.23
- Revenue
- JBIO N/A
- PMM N/A
- Revenue This Year
- JBIO N/A
- PMM N/A
- Revenue Next Year
- JBIO N/A
- PMM N/A
- P/E Ratio
- JBIO N/A
- PMM $26.52
- Revenue Growth
- JBIO N/A
- PMM N/A
- 52 Week Low
- JBIO $1.61
- PMM $5.00
- 52 Week High
- JBIO $13.50
- PMM $6.42
- Technical
- Relative Strength Index (RSI)
- JBIO N/A
- PMM 40.10
- Support Level
- JBIO N/A
- PMM $5.90
- Resistance Level
- JBIO N/A
- PMM $5.86
- Average True Range (ATR)
- JBIO 0.00
- PMM 0.06
- MACD
- JBIO 0.00
- PMM -0.01
- Stochastic Oscillator
- JBIO 0.00
- PMM 17.39
About JBIO JADE BIOSCIENCES INC
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.